Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer
1235.7000 3.30 (0.27%)
NSE Oct 16, 2025 10:33 AM
Volume: 114.0K
 

logo
Dr. Reddy's Laboratories Ltd.
11 May 2023
1235.70
0.27%
buy
by BOB Capital Markets Ltd.
Target: 4900
BOB Capital Markets Ltd.
Q4 broadly in line as revenue/EBITDA grew 16%/35% YoY (-7%/-23% QoQ), albeit aided by one-offs
 
Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades higher, Oberoi Realty's Q2 revenue beats estimates by 31%
Trendlyne Marketwatch | 16 Oct 2025, 10:25AM
Rural India is spending more, but household incomes haven’t caught up
The Baseline | 15 Oct 2025, 01:21PM
Dr Reddy’s Labs struggles in its biggest market
| 18 Aug 2021